Adicet Bio, Inc. — Director's Dealing 2022

Oct 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2022-10-12

Reporting Person: Aftab Blake (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-12	Common Stock	M	3388	$7.38	Acquired	52822	Direct
2022-10-12	Common Stock	S	1646	$15.40	Disposed	51176	Direct
2022-10-13	Common Stock	F	7933	$15.92	Disposed	43243	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-12	Stock Option (Right to Buy)	$7.38	M	3388	Disposed	2031-10-11	Common Stock (3388)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

F3: A total of 60,000 shares subject to an employee stock option were granted to the Reporting Person on October 12, 2021. 25% of the shares subject to the stock option vested and became exercisable on October 12, 2022, with the remainder vesting in equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continued service with the Issuer.